Sensitivity analyses also revealed the stability of our results (Additional file8: Figure S4), indicating that CD44 expression was a prognostic factor for laryngeal and pharyngeal HNSCC patients . This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.